
Startups
Radiology Claims 76% Of FDA-Cleared Medical AI, Study Finds
A peer-reviewed analysis of 1,430 FDA authorization records shows three review panels account for more than 90% of AI-enabled medical devices.
Bootstrapped Wealth reported on GigHz on October 7, 2026.
October 7, 2026
Medical artificial intelligence cleared by US regulators remains heavily clustered in one specialty, according to findings announced on October 6, 2026 by GigHz, a Los Angeles software and research firm started by a physician.

Startups
A peer-reviewed analysis of 1,430 FDA authorization records shows three review panels account for more than 90% of AI-enabled medical devices.